Prediction of lymph node metastases in NSCLC: Three dimensional anatomical parameters do not substitute FDG-PET-CT

NuklearMedizin

Volumn 49, Issue 1, 2010, Pages 41-48

  Beyer, F ^a   Buerke, B ^a   Gerss, J ^a   Scheffe, K ^a   Puesken, M ^a   Weckesser, M ^a   Schober, O ^a   Heindel, W ^a   Wessling, J ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Computed tomography; Computer aided; Diagnostic; FDG PET CT; Helical; Lung cancer; Lymph node; Tumour volumetry

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; THREE DIMENSIONAL IMAGING;

AGED; AUTOMATION; CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 76749157562     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0277     Document Type: Article

References (36)

1. Birim O, Kappetein AP, Stijnen T ,Bogers AJ. Metaanalysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 2005; 79: 375-382.
2. Bollen EC, Goei R, van 't Hof-Grootenboer BE et al. Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer. Ann Thorac Surg 1994; 58: 158-162.
3. Bolte H, Riedel C, Jahnke T et al. Reproducibility of computer-aided volumetry of artificial small pulmonary nodules in ex vivo porcine lungs. Invest Radiol 2006; 41: 28-35.
4. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
5. Cymbalista M, Waysberg A, Zacharias C et al. CT demonstration of the 1996 AJCC-UICC regional lymph node classification for lung cancer staging. Radiographics 1999; 19: 899-900.
6. Das M, Ley-Zaporozhan J, Gietema HA et al. Accuracy of automated volumetry of pulmonary nodules across different multislice CT scanners. Eur Radiol 2007; 17: 1979-1984.
7. Das M, Muhlenbruch G, Katoh M et al. Automated volumetry of solid pulmonary nodules in a phantom: accuracy across different CT scanner technologies. Invest Radiol 2007; 42: 297-302.
8. De Wever W, Meylaerts L, De Ceuninck L et al. Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone. Eur Radiol 2007; 17: 467-473.
9. Dwamena BA, Sonnad SS, Angobaldo JO ,Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology 1999; 213: 530-536.
10. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
11. Erasmus JJ, Gladish GW, Broemeling L et al. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: 2574-2582.
12. Ettinger DS. Overview and state of the art in the management of lung cancer. Oncology 2004; 18 (7 Suppl 4): 3-9.
13. Fabel M, von Tengg-Kobligk H, Giesel FL et al. Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV - a feasibility study. Eur Radiol 2008; 18: 1114-1122.
14. Franzius C. FDG PET: advantages for staging the mediastinum? Lung Cancer 2004; 45 (Suppl 2): S69-S74.
15. Gould MK, Kuschner WG, Rydzak CE et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a metaanalysis. Ann Intern Med 2003; 139: 879-892.
16. Greene F, Page D, Fleming I et al. AJCC Cancer Staging Manual. Heidelberg New York: Springer 2002; 165-177.
17. Hellwig D, Baum RP ,Kirsch C. FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin 2009; 48: 59-69
18. Hellwig D, Groschel A, Graeter TP et al. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2006; 33: 13-21.
19. Heussel CP, Meier S, Wittelsberger S et al. Follow-up CT measurement of liver malignoma according to RECIST and WHO vs. volumetry. Fortschr Roentgen 2007; 179: 958-964.
20. Mahr A, Levegrun S, Bahner ML et al. Usability of semi-automatic segmentation algorithms for tumor volume determination. Invest Radiol 1999; 34: 143-150.
21. Marten K, Auer F, Schmidt S et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur Radiol 2006; 16: 781-790.
22. McLoud TC, Bourgouin PM, Greenberg RW et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
23. Moltz J, Bornemann L ,Kuhnigk J. Advanced segmentation techniques for lung nodules, liver metastases, and enlarges lymph nodes in CT scans. IEEE Trans Med Imag 2009; 1: 122-134.
24. Schaefer NG, Hany TF, Taverna C et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? Radiology 2004; 232: 823-829.
25. Schwartz LH, Bogaerts J, Ford R et al. Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer 2009; 45: 261-267.
26. Schwartz LH, Mazumdar M, Brown W et al. Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement. Clin Cancer Res 2003; 9: 4318-4323.
27. nd ed). Chest 2007; 132 (3 Suppl): 178S-201S.
28. Steinkamp HJ, Cornehl M, Hosten N et al. Cervical lymphadenopathy: ratio of long- to short-axis dia -meter as a predictor of malignancy. Br J Radiol 1995; 68: 266-270.
29. Steinkamp HJ, Hosten N, Richter C et al. Enlarged cervical lymph nodes at helical CT. Radiology 1994; 191: 795-798.
30. Steinkamp HJ, Keske U, Schedel J et al. The spiral CT of cervical lymph node enlargements. The initial clinical results. Röfo 1994; 160: 500-505.
31. Strobel K, Dummer R, Husarik DB et al. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology 2007; 244: 566-574.
32. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123 (1 Suppl): 137S-146S.
33. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992; 183: 215-220.
34. Vorwerk H, Obenauer S, Schmidberger H et al. The significance of a uniform definition of pathological lymph nodes in Hodgkin lymphoma: impact of different thresholds for positive lymph nodes in CT imaging on staging and therapy. Radiother Oncol 2008; 87: 74-81.
35. Wormanns D, Kohl G, Klotz E et al. Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility. Eur Radiol 2004; 14: 86-92.
36. Yankelevitz DF, Reeves AP, Kostis WJ et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217: 251-256.